Precursor Cell Lymphoblastic Leukemia-Lymphoma: all 2,121 studies
Page 14 of 22. Open to participants first (492), then studies with results posted, then the rest; newest registration first within each.
- Cytokine-Treated Veto Cells in Treating Patients With Hematologic Malignancies Following Stem Cell TransplantActive, not recruitingNCT03622788Phase 1/2
- CART22 Alone or in Combination With huCART19 for ALLActive, not recruitingNCT03620058Phase 1
- Feasibility and Effectiveness of Inotuzumab Ozogamicin in B-Cell Acute Lymphoblastic LeukemiaActive, not recruitingNCT03610438Phase 2
- Comparing ATG or Post-Transplant Cyclophosphamide to Calcineurin Inhibitor-Methotrexate as GVHD Prophylaxis After Myeloablative Unrelated Donor Peripheral Blood Stem Cell TransplantationWithdrawnNCT03602898Phase 2
- Immunotherapy With CD19 CART-cells for B Cell Acute Lymphoblastic LeukemiaStatus unknownNCT03599375Phase 1
- Compassionate Use of CAR T Cells Targeting the CD19 Antigen and Containing the Inducible Caspase 9 Safety SwitchNo longer availableNCT03594162
- Evaluate the Neuroprotective Effect of Vitamin B6 and Vitamin B12 Against Vincristine Induced Neurotoxicity in Acute Lymphoblastic Leukaemia PatientsCompletedNCT03593304Phase 2/3
- Expanded Access to NavitoclaxNo longer availableNCT03592576
- Creating a Decision Support System for the Corporate Management of Physical TherapyStatus unknownNCT03586401
- Postural Control Under Different Cognitive Loads in Adult Survivors of Acute Lymphoblastic Leukemia and Age-Matched Healthy IndividualsCompletedNCT03581045
- CD19-Specific T Cells Post AlloSCTTerminatedNCT03579888Phase 1
- CD19-CAR-T Cells in Patients With R/R B-ALLStatus unknownNCT03574168Phase 1
- Study of Prognostic Factors in Adult Lymphoblastic LymphomaStatus unknownNCT03571997
- Precision Diagnosis Directing HDACi Chidamide Target Therapy for Adult T-LBL/ALLStatus unknownNCT03564704Phase 2/3
- Precision Diagnosis Directing HDACi and TKI Target Therapy for Adult Ph-like ALLStatus unknownNCT03564470Phase 2/3
- CD19-targeting CAR T Cells in Relapsed or Refractory CD19 Positive B-cell MalignanciesStatus unknownNCT03559439Phase 1
- Patient-individualized Peptide Vaccination Based on Tumor-specific Mutations in Children and Young Adults With Primary/Relapsed ALLCompletedNCT03559413Phase 1/2
- A Clinical Trial of Decitabine in Relapsed or Refractory T-lymphoblastic LymphomaStatus unknownNCT03558412Phase 4
- A Trial to Evaluate the Potential Impact of Renal Impairment on the Pharmacokinetics and Safety of CPX-351CompletedNCT03555955Phase 1
- Precision Diagnosis Directing HDACi Chidamide Target Therapy for Adult ETP-ALLStatus unknownNCT03553238Phase 2/3
- Childhood Acute Lymphoblastic Leukaemia: Follow-UpCompletedNCT03545659
- CART-19 FOR Relapsed/Refractory Acute Lymphoblastic Leukemia （ALL）Status unknownNCT03544021Phase 1/2
- Blinatumomab Added to Prephase and Consolidation Therapy in Precursor B-acute Lymphoblastic Leukemia in Adults.Active, not recruitingNCT03541083Phase 2
- EphB4-HSA Fusion Protein and Cytarabine /or Liposomal Vincristine in Patients With Recurrent or Refractory Acute LeukemiaTerminatedNCT03519984Phase 1
- A Study to Evaluate Effectiveness and Safety of Ponatinib in Patients With BCR-ABL Positive ALL in Standard Clinical Practice in Europe - "POSEIDON"WithdrawnNCT03515785
- Treatment With Combination Chemotherapy for Relapsed or Refractory Acute Lymphoblastic LeukemiaTerminatedNCT03515200Phase 1
- Pembrolizumab and Blinatumomab in Treating Participants With Recurrent or Refractory Acute Lymphoblastic LeukemiaActive, not recruitingNCT03512405Phase 1/2
- Total Marrow and Lymphoid Irradiation, Fludarabine, and Melphalan Before Donor Stem Cell Transplant in Treating Participants With High-Risk Acute Leukemia or Myelodysplastic SyndromeSuspendedNCT03494569Phase 1
- Trial of AB-110 in Adults With Hematologic Malignancies Undergoing Cord Blood TransplantationCompletedNCT03483324Phase 1
- Palbociclib and Dexamethasone in Treating Participants With Relapsed or Refractory B-Cell Acute Lymphoblastic LeukemiaCompletedNCT03472573Phase 1
- Nutritional Status in Children With ALL in GuatemalaCompletedNCT03471416
- CD19 T-CAR for Treatment of Children and Young Adults With r/r B-ALLActive, not recruitingNCT03467256Phase 1/2
- De-escalated Treatment Approach for Adult Ph-negative Acute Lymphoblastic Leukemia (ALL)Status unknownNCT03462095Not applicable
- Inotuzumab Ozogamicin in Treating Patients With B-cell Acute Lymphocytic Leukemia With Positive Minimal Residual DiseaseActive, not recruitingNCT03441061Phase 2
- Multi-antigen CMV-Modified Vaccinia Ankara Vaccine in Reducing CMV Related Complications in Patients With Blood Cancer Undergoing Donor Stem Cell TransplantWithdrawnNCT03438344Phase 2
- PET/CT and Bacterial/Fungal PCR in High Risk Febrile NeutropeniaCompletedNCT03429387Not applicable
- Clinical Studies of New Model Haploidentical Hematopoietic Stem Cell TransplantationStatus unknownNCT03423706Not applicable
- Multi-modality Imaging and Collection of Biospecimen Samples in Understanding Bone Marrow Changes in Patients With Acute Myeloid Leukemia Undergoing TBI and ChemotherapyActive, not recruitingNCT03422731Early Phase 1
- Comparison of Liposomal Doxorubicin and Daunorubicin-containing VDCLD Regimen in the Treatment of Adult ALL PatientsStatus unknownNCT03419494
- Influences of High-fiber, Organic Whole-food Formula on the Gut Microbiome in Critically Ill ChildrenCompletedNCT03414775Not applicable
- Evaluation of ETC-1907206 With Dasatinib in Advanced Haematologic MalignanciesWithdrawnNCT03414450Phase 1
- Transposon-manipulated Allogeneic CARCIK-CD19 Cells in Pediatric and Adult Patients With r/r ALL Post HSCTCompletedNCT03389035Phase 1/2
- Sequential Chemotherapy and Blinatumomab to Improve MRD Response and Survival in Acute Lymphoblastic LeukemiaCompletedNCT03367299Phase 2
- Anti-CD19 CAR-T Therapy Bridging to HSCT for CD19+ B-Cell MalignanciesStatus unknownNCT03366350Phase 1/2
- Anti-CD19 CAR-T Therapy Combine With HSCT to Treat MRD+ B-cell MalignanciesStatus unknownNCT03366324Phase 1/2
- Pevonedistat With VXLD Chemotherapy for Adolescent/Young Adults With Relapsed/Refractory ALL or Lymphoblastic NHLCompletedNCT03349281Phase 1
- Addition of Gemcitabine to Pre Allo-HSCT Conditioning for Acute Lymphoblastic LeukemiaStatus unknownNCT03339700Phase 2
- Observation of the Effect of Chemotherapy Combined With Tyrosinase Inhibitor on the Reactivation of CMV and EBV in Patients With Acute Lymphoblastic LeukemiaStatus unknownNCT03331211
- Everolimus in Combination With Nelarabine, Cyclophosphamide and Etoposide in Lymphoblastic Leukemia/LymphomaCompletedNCT03328104Phase 1
- C-CAR011 Treatment in Subjects With ALL After HSCTStatus unknownNCT03327285Not applicable
- MB-CART19.1 in Patients With R/R ALLStatus unknownNCT03321123Phase 2
- Post-Frontline Sequential Treatment of Adult Philadelphia Chromosome-Positive Acute Lymphoblastic LeukemiaStatus unknownNCT03318770
- Cladribine in Combination With GAP in Patients With Refractory/Relapsed Acute Lymphoblastic LeukemiaStatus unknownNCT03318419Phase 2
- Study of Gene Modified Donor T-cells Following TCR Alpha Beta Positive Depleted Stem Cell TransplantActive, not recruitingNCT03301168Phase 1/2
- CD19 CAR and PD-1 Knockout Engineered T Cells for CD19 Positive Malignant B-cell Derived Leukemia and LymphomaStatus unknownNCT03298828Phase 1
- ASIA Down Syndrome Acute Lymphoblastic Leukemia 2016Active, not recruitingNCT03286634Phase 2
- Hematotoxicity in Acute Lymphoblastic Leukemia Children in Maintenance Phase TherapyCompletedNCT03279900
- Dependence Receptors and LeukemiaStatus unknownNCT03278145
- CD19 CAR-T Cells With CRS Suppression Technology for r/r CD19+ Acute Lymphoblastic LeukemiaStatus unknownNCT03275493Phase 1/2
- A Clinical Study Evaluating the Safety and Efficacy of BinD19 Treatment in Childhood R/R ALL and Lymphoma SubjectsStatus unknownNCT03265106Phase 1/2
- Study to Assess Safety, Tolerability, Pharmacokinetics and Antitumor Activity of AZD4573 in Relapsed/Refractory Haematological MalignanciesCompletedNCT03263637Phase 1
- CD19 CAR-T Cells for Patients With Relapse and Refractory CD19+ B-ALL.Status unknownNCT03263208Phase 1/2
- Non-interventional, Long-term Follow-up of Subjects Who Completed ApoGraft-01 StudyStatus unknownNCT03260101
- Hematotoxicity in Maintenance Therapy of Children With Acute Lymphoblastic LeukemiaCompletedNCT03255668
- Study of Inotuzumab Ozogamicin Combined to Chemotherapy in Older Patients With Philadelphia Chromosome-negative CD22+ B-cell Precursor ALLCompletedNCT03249870Phase 2
- New Markers for Minimal Residual Disease in Acute Lymphoblastic LeukemiaStatus unknownNCT03249636
- Study of CD19/CD22 Chimeric Antigen Receptor T Cells in Children & Young Adults w/ Recurrent or Refractory B Cell MalignanciesActive, not recruitingNCT03241940Phase 1
- A Study of the Safety and Pharmacokinetics of Venetoclax in Pediatric and Young Adult Patients With Relapsed or Refractory MalignanciesCompletedNCT03236857Phase 1
- Cladribine Dose Escalation in Conditioning Regimen Prior to Allo-HSCT for Refractory Acute Leukemia and Myelodysplastic SyndromesStatus unknownNCT03235973Phase 1
- Evaluating a Knowledge Translation Tool for ParentsCompletedNCT03234777Not applicable
- Safety and Efficacy Evaluation of CD19-UCARTSuspendedNCT03229876Not applicable
- Trial Evaluating the Efficacy and Safety of Daratumumab in Subjects With Relapsed/Refractory B-cell or T-cell Precursor Acute Lymphoblastic Leukemia (ALL)WithdrawnNCT03207542Phase 2
- Cancer Care Delivery in Adolescent and Young Adult Patients With Acute Lymphoblastic LeukemiaCompletedNCT03204916
- A Study of Anti-CD19 CAR-T Cell Immunotherapy for Refractory /Relapsed B Cell MalignanciesStatus unknownNCT03191773Phase 1/2
- Quality of Life in Children With CancerCompletedNCT03190499
- Cognitive Intervention at the End of Therapy for Survivors of Childhood ALL Treated on TOTXVICompletedNCT03187977Not applicable
- Safety and PK of Oral Encochleated Amphotericin B (CAMB/MAT2203) for Antifungal Prophylaxis in Patients Undergoing Induction Chemotherapy for Acute Myelogenous and Lymphoblastic LeukaemiaWithdrawnNCT03187691Phase 2
- Pilot Study of T-APCs Following CAR T Cell Immunotherapy for CD19+ LeukemiaActive, not recruitingNCT03186118Phase 1
- Treatment of Relapsed and/or Chemotherapy Refractory B-cell Malignancy by Tandem CAR T Cells Targeting CD19 and CD22Status unknownNCT03185494Phase 1/2
- A Study of Venetoclax in Combination With Navitoclax and Chemotherapy in Subjects With Relapsed/Refractory Acute Lymphoblastic Leukemia or Relapsed/Refractory Lymphoblastic LymphomaCompletedNCT03181126Phase 1
- High-Intensity Parent Intervention Program in Improving Learning and School Functioning in Latino Children With Acute Leukemia or Lymphoblastic LymphomaActive, not recruitingNCT03178617Not applicable
- A Randomized Phase IV Control Trial of Single High Dose Oral Vitamin D3 in Pediatric Patients Undergoing HSCTCompletedNCT03176849Phase 4
- Low GI Diet in Children and Adolescents With ALLActive, not recruitingNCT03157323Not applicable
- PK, PD, Safety and Immunogenicity of Spectrila in Adults With Acute B-cell Lymphoblastic LeukaemiaTerminatedNCT03156790Phase 2
- A Clinical Study Evaluating the Safety and Efficacy of BinD19 Treatment in R/R ALL and Lymphoma SubjectsStatus unknownNCT03156101Phase 1/2
- Study of TBI-1501 for Relapsed or Refractory Acute Lymphoblastic LeukemiaActive, not recruitingNCT03155191Phase 1/2
- Low-Intensity Chemotherapy, Ponatinib and Blinatumomab in Treating Patients With Philadelphia Chromosome-Positive and/or BCR-ABL Positive Acute Lymphoblastic LeukemiaActive, not recruitingNCT03147612Phase 2
- Effect of Different Exercises on Quality of Life of Leukemia Patients.CompletedNCT03147365Not applicable
- Comparing CGM and OGTT in Relation to Iron Overload Detected by Pancreas T2* MRI in High-Risk Hematology GroupWithdrawnNCT03141398
- Palbociclib and Sorafenib, Decitabine, or Dexamethasone in Treating Patients With Recurrent or Refractory LeukemiaActive, not recruitingNCT03132454Phase 1
- Evaluate the Hematological Remission Rates and Survival Among Chinese Adult Patients With B-precursor ALLCompletedNCT03123887
- Metformin Reduce the Relapse Rate on Patients With B-cell Precursor (Ph+ Negative) Acute Lymphoblastic LeukemiaCompletedNCT03118128Not applicable
- Total Therapy XVII for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia and LymphomaActive, not recruitingNCT03117751Phase 2/3
- A Study of Blinatumomab in Patients With Pre B-cell ALL and B-cell NHL as Post-allo-HSCT Remission MaintenanceActive, not recruitingNCT03114865Phase 1/2
- Anti-CD19 CAR T Infusion Combined With Allogeneic Stem Cell Transplantation for B-cell Leukemia/LymphomaStatus unknownNCT03110640Phase 1
- Blinatumomab in Adult Patients With Minimal Residual Disease (MRD) of B-precursor Acute Lymphoblastic LeukemiaCompletedNCT03109093Phase 2
- huJCAR014 CAR-T Cells in Treating Adult Patients With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma or Acute Lymphoblastic LeukemiaTerminatedNCT03103971Phase 1
- Treatment of Relapsed and/or Chemotherapy Refractory B-cell Malignancy by Tandem CAR T Cells Targeting CD19 and CD20CompletedNCT03097770Phase 1/2
- Haploidentical Stem Cell Transplantation Using Post-Transplant CyclophosphamideTerminatedNCT03088709Phase 2
- Anti-CD19 Chimeric Antigen Receptor (CAR)-Transduced T Cell Therapy for Patients With B Cell MalignanciesCompletedNCT03076437Phase 1/2